Acceso abierto

In vitro investigation of anti-inflammatory activity of propolis/saffron extract/curcumin-loaded ZIF8 nanoparticles and their potential application for treating osteoarthritis

Hongtao Zhang
Hongtao Zhang
, 
Kui Xu
Kui Xu
, 
Zhen Zhao
Zhen Zhao
, 
Chuan Dong
Chuan Dong
 y 
Yunfei Zhang
Yunfei Zhang
   | 11 jul 2024
Materials Science-Poland's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Publicado en línea: 11 jul 2024
Páginas: 41 - 51
Recibido: 21 abr 2024
Aceptado: 19 may 2024
DOI: https://doi.org/10.2478/msp-2024-0016
Palabras clave
© 2024 Hongtao Zhang et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Fig. 1.

Representative SEM imaging results for (A) ZIF, (B) PROZIF, (C) SAFROZIF, and (D) CURCUZIF nanocarriers and their size distribution
Representative SEM imaging results for (A) ZIF, (B) PROZIF, (C) SAFROZIF, and (D) CURCUZIF nanocarriers and their size distribution

Fig. 2.

MTT assay with L929 cells cultured with different concentrations of (A) PROZIF, (B) SAFROZIF, (C) CURCUZIF, and (D) ZIF nanoparticles, a, b, and e show p-values < 0.05 relative to 1 μg/mL, 10 μg/mL, and control groups, respectively
MTT assay with L929 cells cultured with different concentrations of (A) PROZIF, (B) SAFROZIF, (C) CURCUZIF, and (D) ZIF nanoparticles, a, b, and e show p-values < 0.05 relative to 1 μg/mL, 10 μg/mL, and control groups, respectively

Fig. 3.

Histograms comparing the anti-inflammatory activity of (A) PROZIF, (B) SAFROZIF, (C) CURCUZIF, and (D) ZIF nanoparticles at different concentrations, a, b, c, and d show p-value < 0.05 relative to 1 μg/mL, 10 μg/mL, 100 μg/mL, and 1000 μg/mL concentrations, respectively
Histograms comparing the anti-inflammatory activity of (A) PROZIF, (B) SAFROZIF, (C) CURCUZIF, and (D) ZIF nanoparticles at different concentrations, a, b, c, and d show p-value < 0.05 relative to 1 μg/mL, 10 μg/mL, 100 μg/mL, and 1000 μg/mL concentrations, respectively

Fig. 4.

Histograms comparing the anti-inflammatory activity of ZIF, PROZIF, SAFROZIF, and CURCUZIF at (A) 1 μg/mL, (B) 10 μg/mL, (C) 100 μg/mL, and (D) 1000 μg/mL concentrations
Histograms comparing the anti-inflammatory activity of ZIF, PROZIF, SAFROZIF, and CURCUZIF at (A) 1 μg/mL, (B) 10 μg/mL, (C) 100 μg/mL, and (D) 1000 μg/mL concentrations

Fig. 5.

Cell migration assay with L929 cells cultured with different nanocarriers on day 0 (left panel), day 1 (middle panel), and day 2 (right panel), a shows p-value < 0.05 relative to PROZIF group
Cell migration assay with L929 cells cultured with different nanocarriers on day 0 (left panel), day 1 (middle panel), and day 2 (right panel), a shows p-value < 0.05 relative to PROZIF group

Fig. 6.

FTIR spectra of ZIF, PROZIF, SAFROZIF, and CURCUZIF nanoparticles
FTIR spectra of ZIF, PROZIF, SAFROZIF, and CURCUZIF nanoparticles

Fig. 7.

Cumulative release profile of propolis, saffron extract, and curcumin from PROZIF, SAFROZIF, and CURCUZIF during the course of 7 days in PBS
Cumulative release profile of propolis, saffron extract, and curcumin from PROZIF, SAFROZIF, and CURCUZIF during the course of 7 days in PBS
eISSN:
2083-134X
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Materials Sciences, other, Nanomaterials, Functional and Smart Materials, Materials Characterization and Properties
RSS Feed de revista